Interspace Co.,Ltd.
Interspace Co.,Ltd. (2122.T) Financial Performance & Income Statement Overview
Review Interspace Co.,Ltd. (2122.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Interspace Co.,Ltd. (2122.T) Income Statement & Financial Overview
Review Interspace Co.,Ltd. 2122.T income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.08B | $1.97B | $1.94B | $2.16B |
| Cost of Revenue | $380.41M | $398.00M | $405.36M | $401.48M |
| Gross Profit | $1.70B | $1.57B | $1.54B | $1.76B |
| Gross Profit Ratio | $0.82 | $0.80 | $0.79 | $0.81 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.59B | $1.54B | $1.45B | $1.46B |
| Operating Expenses | $1.59B | $1.54B | $1.45B | $1.46B |
| Total Costs & Expenses | $1.97B | $1.94B | $1.85B | $1.86B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $59.48M | $69.75M | $71.16M | $1000.00 |
| EBITDA | $163.37M | $99.75M | $162.55M | $299.13M |
| EBITDA Ratio | $0.08 | $0.05 | $0.08 | $0.14 |
| Operating Income | $105.20M | $31.00M | $89.37M | $299.13M |
| Operating Income Ratio | $0.05 | $0.02 | $0.05 | $0.14 |
| Other Income/Expenses (Net) | $50.03M | -$210.00M | $2.02M | $2.37M |
| Income Before Tax | $155.23M | -$179.00M | $91.39M | $301.50M |
| Income Before Tax Ratio | $0.07 | -$0.09 | $0.05 | $0.14 |
| Income Tax Expense | $64.75M | $37.00M | $66.66M | $119.64M |
| Net Income | $90.48M | -$216.00M | $24.73M | $181.86M |
| Net Income Ratio | $0.04 | -$0.11 | $0.01 | $0.08 |
| EPS | $14.41 | -$34.41 | $3.94 | $29.00 |
| Diluted EPS | $14.41 | -$34.41 | $3.94 | $29.00 |
| Weighted Avg Shares Outstanding | $6.28M | $6.28M | $6.28M | $6.28M |
| Weighted Avg Shares Outstanding (Diluted) | $6.28M | $6.28M | $6.28M | $6.28M |
The company's financials show resilient growth, with revenue advancing from $2.16B in Q2 2024 to $2.08B in Q1 2025. Gross profit remained healthy with margins at 82% in Q1 2025 compared to 81% in Q2 2024. Operating income hit $105.20M last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $163.37M. Net income rose to $90.48M, while earnings per share reached $14.41. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan